Appointment of Interim Chief Executive Officer
Filed with ASX · · 1 page · English
Summary by 6ix AI
Microba Life Sciences Limited has announced the appointment of Mr. Geoffrey Cockerill as Interim Chief Executive Officer while Dr. Luke Reid is on medical leave. His engagement as Interim CEO will last for an initial term of six months, with specific terms outlined in the announcement. The announcement has been authorized for release by the Board of Directors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings CallMicroba Life Sciences Limited on 6ix
Story so far
Earlier from Microba Life Sciences
- GSS and MAP agree to Commercial Terms for Merger
- 2026 Annual Report & Appendix 4E
- 2026 Appendix 4G
- 2026 Corporate Governance Statement
- Genetic Signatures and Microba in Merger Discussions
Later from Microba Life Sciences
- Change in substantial holding
- Microba launches GI Navigator in Australia and the UK
- Notification of cessation of securities - MAP
- Date of AGM and closing date for Director Nominations
- Microba secures $2m placement and increases cost reductions
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences